Search

Dr. Sue Sisley at Scottsdale Research Institute (SRI), along with three military veterans, has filed suit against the DEA challenging the application of a test developed in 1992 used to classify drugs based on their medical applications. Currently, usage of the 1992 test is what keeps marijuana classified as a Schedule I drug under the Controlled Substances Act (CSA). Dr. Sisley and SRI are committed to studying the benefits of cannabis used to treat post-traumatic stress disorder (PTSD) in military veterans and argue that the low quality of the marijuana they are permitted to use does not allow scientists to successfully study these effects. Many researchers, in addition to SRI, have long complained about the “catch 22” of studying the medical effects of cannabis due to the DEA’s requirement that only government-grown marijuana may be used for medical studies.

Currently, only one facility in the country (located in Mississippi) is permitted to grow marijuana for medical research and the resulting product has very low levels of THC. In 2016, the DEA announced that it would consider applications from outside cannabis cultivators to supply non-government grown marijuana for medical research purposes in order to remedy this. Finally, after years of dragging its feet, the agency announced in March of this year that it would be making fundamental changes to its policies in order to expedite the authorization of outside growers.


Through the lawsuit, Dr. Sisley hopes to facilitate this process even further by having marijuana reclassified as a Schedule III substance under the CSA which would allow researchers to more easily obtain commercial-grade flower and would hopefully pave the way to more serious conversations about federal legalization.


Raffi Garnighian is a published author and Colorado and New York licensed attorney at Wysocki Law Group, P.C. Emily Bennett is a law student at the University of Denver School of Law and assisted in the publication of this article.


© Wysocki Law Group 2020. All rights reserved. All opinions published herein are those of the individual authors and are not to be construed as legal advice. Please contact Wysocki Law Group for any legal questions you may have in response to this article or any others.

Updated: Apr 21

The U.S. Small Business Association (“SBA”) created the $349 billion emergency Paycheck Protection Program (“PPP”), as described under the Coronavirus Aid, Relief, and Economic Security (“CARES") Act, to provide economic relief to small business impacted by COVID-19. The programs intention is to incentivize small businesses with fewer than 500 employees to keep their workers on payroll. However, it appears that some large publicly traded corporations have become eligible for the loan by not employing over 500 employees at a single location.


Shake Shack is the largest publicly traded company to receive a loan under the program with a market capitalization of $1.6 billion and well over 7,000 employees. They became eligible for the program because they do not employ over 500 people at a single location. The $10 million loan that they received through the program was the maximum amount allotted. Shake Shack promises to return the loan, due to having $112 million of cash on hand and recently selling another $150 million worth of stock.


As Congress and the Trump Administration work to replenish the funding for another round of PPP loans, it will be interesting to see if there will be stricter stipulations on who will be eligible. If the true intention of the program is to supply small business with economic relief, then a more stringent application process is necessary.


Budletter will continue to monitor the situation as it further develops.

Raffi Garnighian is a published author and Colorado and New York licensed attorney at Wysocki Law Group, P.C. Mitchell Steeves is a law student at the University of Colorado School of Law and assisted in the publication of this article.


© Wysocki Law Group 2020. All rights reserved. All opinions published herein are those of the individual authors and are not to be construed as legal advice. Please contact Wysocki Law Group for any legal questions you may have in response to this article or any others.

Today, the U.S. Small Business Association ("SBA") stopped accepting applications for funding under the Paycheck Protection Program ("PPP"), as described under the Coronavirus Aid, Relief, and Economic Security ("CARES") Act. The SBA stated that the $349 billion in funding provided by Congress under the CARES Act had been exhausted after it had processed over 1.6 million loan applications in the first weeks of the program.


While the SBA has urged Congress to increase the available funding for the program, no statement has been made suggested that such an increase will or will not occur.


Budletter will continue to monitor the situation as it further develops.


© Wysocki Law Group 2020. All rights reserved. All opinions published herein are those of the individual authors and are not to be construed as legal advice. Please contact Wysocki Law Group for any legal questions you may have in response to this article or any others.

OUR LEGAL EXPERTISE 

If you found what you've read informative and would like to reach out with your legal questions, please contact our firm below.

 

Wysocki Law Group, P.C. is a nationally and internationally recognized boutique law firm based at the foothills of the Rocky Mountains in Denver, Colorado. We effectively assist clients with a wide variety of corporate, complex commercial litigation, cannabis, employment, and real estate matters.

 

Contact us below for more information.

Contact Us

Tel: 952-715-8002

rgarnighian@wysocki.law

Copy of Untitled (1).png

© 2020 Wysocki Law Group, P.C.